[go: up one dir, main page]

AU2002229037A1 - Protein-protein complexes and methods of using same - Google Patents

Protein-protein complexes and methods of using same

Info

Publication number
AU2002229037A1
AU2002229037A1 AU2002229037A AU2903702A AU2002229037A1 AU 2002229037 A1 AU2002229037 A1 AU 2002229037A1 AU 2002229037 A AU2002229037 A AU 2002229037A AU 2903702 A AU2903702 A AU 2903702A AU 2002229037 A1 AU2002229037 A1 AU 2002229037A1
Authority
AU
Australia
Prior art keywords
protein
methods
same
complexes
protein complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002229037A
Inventor
Andrew J. Eisen
Loic Giot
David A. Lewin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CuraGen Corp filed Critical CuraGen Corp
Publication of AU2002229037A1 publication Critical patent/AU2002229037A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002229037A 2000-10-30 2001-10-30 Protein-protein complexes and methods of using same Abandoned AU2002229037A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24423600P 2000-10-30 2000-10-30
US60/244,236 2000-10-30
PCT/US2001/048162 WO2002036766A2 (en) 2000-10-30 2001-10-30 Protein-protein complexes and methods of using same

Publications (1)

Publication Number Publication Date
AU2002229037A1 true AU2002229037A1 (en) 2002-05-15

Family

ID=22921930

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002229037A Abandoned AU2002229037A1 (en) 2000-10-30 2001-10-30 Protein-protein complexes and methods of using same

Country Status (3)

Country Link
US (1) US20030157554A1 (en)
AU (1) AU2002229037A1 (en)
WO (1) WO2002036766A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7054758B2 (en) 2001-01-30 2006-05-30 Sciona Limited Computer-assisted means for assessing lifestyle risk factors
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871697A (en) * 1995-10-24 1999-02-16 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
CN1296966A (en) * 1999-11-23 2001-05-30 上海博容基因开发有限公司 Polypeptide-human SR splicing factor 52 and polynucleotide for coding said polypeptide

Also Published As

Publication number Publication date
US20030157554A1 (en) 2003-08-21
WO2002036766A2 (en) 2002-05-10
WO2002036766A3 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
AU2001251358A1 (en) Prion-binding ligands and methods of using same
AU2001280599A1 (en) Compounds and methods
AU2002314466A1 (en) Withasol and methods of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001253418A1 (en) Compounds and methods
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2001243394A1 (en) Compounds and methods
AU2001236716A1 (en) Antigenic complexes and methods
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AUPQ872300A0 (en) Compounds and methods
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002359694A1 (en) Compounds and methods
AU2003215244A1 (en) Complexes and methods of using same
AU1083501A (en) Antibiotic-metal complex and methods
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2001278951A1 (en) Compounds and methods
AU2002312373A1 (en) Structural and cytoskeleton-associated proteins
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2002235277A1 (en) Compounds and methods
AU2136401A (en) P450rai-2 and related proteins
AU2002229037A1 (en) Protein-protein complexes and methods of using same
AU2002256556A1 (en) Sea-trosy and related methods
AU3863900A (en) Prolyl peptidases and methods of use
AU2001277519A1 (en) Bio-probes and use thereof
AU2002221222A1 (en) Novel method and use